These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Study of the association of bladder cancer and phenacetin use. Problems set by a pharmaco-epidemiological study]. Berleur MP; Cordier S Therapie; 1992; 47(3):231-8. PubMed ID: 1295123 [TBL] [Abstract][Full Text] [Related]
26. Regulation and control of the medical profession in Great Britain. Fry J Int J Health Serv; 1976; 6(1):5-7. PubMed ID: 939614 [TBL] [Abstract][Full Text] [Related]
27. Effect of 3-methylcholanthrene pretreatment on the bioavailability of phenacetin in the rat. Welch RM; Hughes CR; Deangelis RL Drug Metab Dispos; 1976; 4(4):402-6. PubMed ID: 8296 [TBL] [Abstract][Full Text] [Related]
28. Aspirin, phenacetin, and the kidney: a rheumatism clinic study. Ferguson I; Johnson F; Reay B; Wigley R Med J Aust; 1977 Jun; 1(26):950-4. PubMed ID: 887037 [TBL] [Abstract][Full Text] [Related]
30. Genotoxicity of phenacetin in the kidney and liver of Sprague-Dawley gpt delta transgenic rats in 26-week and 52-week repeated-dose studies. Kawamura Y; Hayashi H; Masumura K; Numazawa S; Nohmi T Toxicology; 2014 Oct; 324():10-7. PubMed ID: 25047350 [TBL] [Abstract][Full Text] [Related]
31. Remarks on the Therapeutic Uses and Effects of Antipyrin. Hehir P Ind Med Gaz; 1891 Oct; 26(10):292-296. PubMed ID: 29000703 [No Abstract] [Full Text] [Related]
32. Phenacetin and the liver. The influence of phenacetin in acute and chronic doses on membrane-bound mitochondrial enzymes in the rat. Raab W; Kramar R; Moerth C Enzyme; 1976; 21(3):275-8. PubMed ID: 1278138 [TBL] [Abstract][Full Text] [Related]
33. [Abuse of phenacetin-containing analgesics and carcinoma of the renal pelvis (author's transl)]. Syré G; Matejka M Wien Klin Wochenschr; 1981 Jun; 93(13):420-3. PubMed ID: 7269623 [TBL] [Abstract][Full Text] [Related]
34. [Methemoglobinemia following administration of phenacetin and acet-4-chloranilide]. GAD I; JACOBSEN E; MADSEN S; SCHMITH K Ugeskr Laeger; 1950 Oct; 112(41):1405-11. PubMed ID: 14798669 [No Abstract] [Full Text] [Related]
35. The addiction potential of oxycodone (Percodan). BLOOMQUIST ER Calif Med; 1963 Aug; 99(2):127-30. PubMed ID: 13971810 [TBL] [Abstract][Full Text] [Related]
36. Reports to the Parliamentary Bills Committee and Therapeutic Committee of the British Medical Association. Br Med J; 1894 Jan; 1(1724):79-84. PubMed ID: 20754617 [No Abstract] [Full Text] [Related]
37. [ANEMIA FOLLOWING ABUSE OF PHENACETIN]. RZESNIOWIECKI J; WIELGUS R Pol Tyg Lek; 1964 Aug; 19():1196-8. PubMed ID: 14202968 [No Abstract] [Full Text] [Related]
38. An epidemiologic study of abuse of analgesic drugs. Effects of phenacetin and salicylate on mortality and cardiovascular morbidity (1968 to 1987). Dubach UC; Rosner B; Stürmer T N Engl J Med; 1991 Jan; 324(3):155-60. PubMed ID: 1984193 [TBL] [Abstract][Full Text] [Related]
39. Phenacetin nephropathy, with particular reference to the effect of surgery. Koutsaimanis KG; de Wardener HE Br Med J; 1970 Oct; 4(5728):131-4. PubMed ID: 5475815 [TBL] [Abstract][Full Text] [Related]
40. Effects of oral methoxy-psoralen photochemotherapy (PUVA) on liver function and antipyrin kinetics. Chretien P; Galmiche JP; Payenneville JM; Fouin-Fortunet H; Lauret P; Boismare F; Colin R Int J Clin Pharmacol Res; 1983; 3(5):343-7. PubMed ID: 6678827 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]